OncoMyx Presents New Data at AACR 2022 on Multi-Armed Myxoma Virus Coordinates
08 Apr 2022 //
BUSINESSWIRE
OncoMyx Appoints Robert Williamson Chief Business and Chief Financial Officer
02 Mar 2022 //
BUSINESSWIRE
OncoMyx nabs $50M to jump into the clinic
08 Dec 2021 //
FIERCEBIOTECH
Underpinning Sinema’s outspoken opposition to major drug pricing reforms
19 Oct 2021 //
STATNEWS
OncoMyx Gets Exclusive Option to License IP Rights for Myxoma Virus Technology
15 Jun 2021 //
BUSINESSWIRE
OncoMyx`s modified rabbit pox virus shows promise in lung cancer
13 Apr 2021 //
FIEREBIOTECH
OncoMyx Announces Presentation of Preclinical Efficacy Data of Novel Oncolytic
09 Nov 2020 //
BUSINESSWIRE